FdaApplication

NDA 019151

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLAXOSMITHKLINE LLC
application_typeNDA
approval_date1989-11-27

Products (3)

ProductActive ingredientStrengthDosage form
RYTHMOLPROPAFENONE HYDROCHLORIDE300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
RYTHMOLPROPAFENONE HYDROCHLORIDE225MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
RYTHMOLPROPAFENONE HYDROCHLORIDE150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

3 products